Successful treatment with pazopanib plus PD-1 inhibitor and RAK cells for advanced primary hepatic angiosarcoma: A case report

19Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Primary hepatic angiosarcoma (PHA) is a rare and aggressive solid tumor, with high rates of local recurrence and distant metastasis, and poor prognosis. There are no established treatment guidelines for PHA. Case presentation: A 78-year-old asymptomatic man with PHA that was successfully treated with pazopanib plus PD-1 inhibitor and RetroNectin-activated killer cells (RAK cells). After one month of treatment, there was a clear reduction in the size and number of the liver metastases; and after nearly 15months, most of the lesions were stable, no new lesions had developed, and the side effect of treatment was minor. Conclusion: Pazopanib, PD-1 inhibitor and RAK cells could serve as a potential option for the treatment of advanced PHA.

References Powered by Scopus

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): A randomised, double-blind, placebo-controlled phase 3 trial

1721Citations
N/AReaders
Get full text

Combining immunotherapy and targeted therapies in cancer treatment

1299Citations
N/AReaders
Get full text

Primary hepatic angiosarcoma and potential treatment options

89Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Adverse events of concurrent immune checkpoint inhibitors and antiangiogenic agents: A systematic review

38Citations
N/AReaders
Get full text

Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: Insights from genomic sequencing

35Citations
N/AReaders
Get full text

A pooled analysis of primary hepatic angiosarcoma

20Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Qiao, Y., Yang, J., Liu, L., Zeng, Y., Ma, J., Jia, J., … Wang, Y. (2018). Successful treatment with pazopanib plus PD-1 inhibitor and RAK cells for advanced primary hepatic angiosarcoma: A case report. BMC Cancer, 18(1). https://doi.org/10.1186/s12885-018-3996-3

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

56%

Professor / Associate Prof. 3

33%

Researcher 1

11%

Readers' Discipline

Tooltip

Medicine and Dentistry 9

75%

Computer Science 1

8%

Nursing and Health Professions 1

8%

Engineering 1

8%

Save time finding and organizing research with Mendeley

Sign up for free